27 Oct 2021 --- China’s Ministry of Agriculture and Rural Affairs (MARA) has confirmed the safety of six manufacturing strains to produce human milk oligosaccharides (HMOs), thus opening up the regulatory pathway. DSM, which filed HMO manufacturing strain safety dossiers, is celebrating the move as a “critical milestone” in the journey to providing products – such as infant formula – with these novel ingredients in China.
